Medical Therapy in Cushing's Disease: New Targets, New Hope!

22 October 2013

 

Learning Objectives

  • Assess available therapies, including new medical options for Cushing's disease
  • Evaluate patient response to therapy for Cushing's disease
  • Discuss possible combination therapy for treatment of hypercortisolemia

Presenter Bio

Dr Fleseriu is an Associate Professor of Medicine and Neurological Surgery and Director of the Northwest Pituitary Center at Oregon Health & Science University (OHSU), Portland, OR, USA. She graduated summa cum laude from the University of Medicine and Pharmacy of Timisoara, Romania and completed residency training in internal medicine and an endocrinology fellowship with a focus in pituitary disorders in Romania. Subsequently, she completed an additional internal medicine residency at Case Western Reserve University, and an endocrinology fellowship at Cleveland Clinic in the US.

Dr Fleseriu has a long-standing clinical and research interest in the pathophysiology and treatment of pituitary and adrenal diseases and has published extensively, including several book chapters. Her recent research is devoted to new treatments of pituitary tumors; internationally collaborative studies include treatment with short- and long-acting novel multiligands somatostatin analogs, adrenal steroidogenesis inhibitors and glucocorticoid receptor blocker. She is a frequent national and international guest speaker on various topics related to treatments of pituitary tumors, especially acromegaly and Cushing's disease. She is a senior editor for Endocrinology, Diabetes & Metabolism CR, a guest editor for the Cushing's syndrome issue for International Journal of Endocrinology, a long-time member of the editorial boards for Pituitary and Faculty of 1000 and a reviewer for numerous journals. She also currently serves on The Endocrine Society Clinical Guidelines Committee.

Her clinical practice focuses on the diagnosis and treatment of pituitary and adrenal tumors and pituitary dysfunction, with a particular interest in acromegaly and Cushing's disease. As the Director of the Northwest Pituitary Center at OHSU, Dr Fleseriu champions a balanced approach to clinical management, combining the most recent advances in the field of neuroendocrinology and the aggressive pursuit of multidisciplinary research. She has been a PNA collaborator for several years and she authored several chapters regarding Cushing's syndrome, pituitary disorders in women, headache and acromegaly in the PNA's Wiley-Blackwell book: "Pituitary Disorders: Diagnosis and Management" and the 5th edition of the Pituitary Patient Resource Guide.

 

  • Maria Fleseriu, M.D.
    Northwest Pituitary Center Departments of Medicine and Neurological Surgery, Oregon Health & Science University

Description

 

Learning Objectives

  • Assess available therapies, including new medical options for Cushing's disease
  • Evaluate patient response to therapy for Cushing's disease
  • Discuss possible combination therapy for treatment of hypercortisolemia

Presenter Bio

Dr Fleseriu is an Associate Professor of Medicine and Neurological Surgery and Director of the Northwest Pituitary Center at Oregon Health & Science University (OHSU), Portland, OR, USA. She graduated summa cum laude from the University of Medicine and Pharmacy of Timisoara, Romania and completed residency training in internal medicine and an endocrinology fellowship with a focus in pituitary disorders in Romania. Subsequently, she completed an additional internal medicine residency at Case Western Reserve University, and an endocrinology fellowship at Cleveland Clinic in the US.

Dr Fleseriu has a long-standing clinical and research interest in the pathophysiology and treatment of pituitary and adrenal diseases and has published extensively, including several book chapters. Her recent research is devoted to new treatments of pituitary tumors; internationally collaborative studies include treatment with short- and long-acting novel multiligands somatostatin analogs, adrenal steroidogenesis inhibitors and glucocorticoid receptor blocker. She is a frequent national and international guest speaker on various topics related to treatments of pituitary tumors, especially acromegaly and Cushing's disease. She is a senior editor for Endocrinology, Diabetes & Metabolism CR, a guest editor for the Cushing's syndrome issue for International Journal of Endocrinology, a long-time member of the editorial boards for Pituitary and Faculty of 1000 and a reviewer for numerous journals. She also currently serves on The Endocrine Society Clinical Guidelines Committee.

Her clinical practice focuses on the diagnosis and treatment of pituitary and adrenal tumors and pituitary dysfunction, with a particular interest in acromegaly and Cushing's disease. As the Director of the Northwest Pituitary Center at OHSU, Dr Fleseriu champions a balanced approach to clinical management, combining the most recent advances in the field of neuroendocrinology and the aggressive pursuit of multidisciplinary research. She has been a PNA collaborator for several years and she authored several chapters regarding Cushing's syndrome, pituitary disorders in women, headache and acromegaly in the PNA's Wiley-Blackwell book: "Pituitary Disorders: Diagnosis and Management" and the 5th edition of the Pituitary Patient Resource Guide.

 

Available Now!

PPRG6-500 Cover
The Pituitary Patient Resource Guide Sixth Edition is now available! Be one of the first to have the most up-to-date information. The Pituitary Patient Resource Guide a one of a kind publication intended as an invaluable source of information not only for patients but also their families, physicians, and all health care providers. It contains information on symptoms, proper testing, how to get a diagnosis, and the treatment options that are available. It also includes Pituitary Network Association's patient resource listings for expert medical care.

Buy Now